gabi u dachs
University of Otago, Christchurch
Christchurch, New Zealand
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Otago, Christchurch
Christchurch, New Zealand
Associate Editor
Cancer Molecular Targets and Therapeutics
Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of liverpool
Liverpool, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Washington University in St. Louis
St. Louis, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
Department of Pathology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Associate Editor
Molecular and Cellular Oncology
Shenzhen Hospital, Peking University
Shenzhen, China
Associate Editor
Gynecological Oncology
Jilin University
Changchun, China
Associate Editor
Cancer Immunity and Immunotherapy
First Affiliated Hospital of Jilin University
Changchun, China
Associate Editor
Cancer Molecular Targets and Therapeutics
Case Western Reserve University
Cleveland, United States
Associate Editor
Hematologic Malignancies
Hematology and Stem Cell Transplant,
Udine, Italy
Associate Editor
Hematologic Malignancies
University of Kansas Medical Center
Kansas City, United States
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Paras Cancer Centre
Patna, India
Associate Editor
Head and Neck Cancer
University of Ferrara
Ferrara, Italy
Associate Editor
Molecular and Cellular Oncology
University of Pisa
Pisa, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Agostino Gemelli University Polyclinic (IRCCS)
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
TCG Lifesciences (India)
Calcutta, India
Associate Editor
Cancer Immunity and Immunotherapy